Skip to Main Content

Paper Details

Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement.
Haematologica
3
2022
Author NameAffiliation
Laurence Brugi??resGustave Roussy Cancer Center, Paris-Saclay University
  • 1 - 1

Datasets

Release 1.2